Global Stem Cell Therapy for Multiple Sclerosis Market Research Report 2023

Report ID: 1989131 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Intravenous
        1.2.3 Intracerebroventricular
    1.3 Market by Application
        1.3.1 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Relapsing-Remitting Multiple Sclerosis (RRMS)
        1.3.3 Primary Progressive Multiple Sclerosis (PPMS)
        1.3.4 Secondary Progressive Multiple Sclerosis (SPMS)
        1.3.5 Progressive Relapsing Multiple Sclerosis (PRMS)
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Stem Cell Therapy for Multiple Sclerosis Market Perspective (2017-2028)
    2.2 Stem Cell Therapy for Multiple Sclerosis Growth Trends by Region
        2.2.1 Stem Cell Therapy for Multiple Sclerosis Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Region (2017-2022)
        2.2.3 Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Region (2023-2028)
    2.3 Stem Cell Therapy for Multiple Sclerosis Market Dynamics
        2.3.1 Stem Cell Therapy for Multiple Sclerosis Industry Trends
        2.3.2 Stem Cell Therapy for Multiple Sclerosis Market Drivers
        2.3.3 Stem Cell Therapy for Multiple Sclerosis Market Challenges
        2.3.4 Stem Cell Therapy for Multiple Sclerosis Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Revenue
        3.1.1 Global Top Stem Cell Therapy for Multiple Sclerosis Players by Revenue (2017-2022)
        3.1.2 Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Players (2017-2022)
    3.2 Global Stem Cell Therapy for Multiple Sclerosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Stem Cell Therapy for Multiple Sclerosis Revenue
    3.4 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio
        3.4.1 Global Stem Cell Therapy for Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Multiple Sclerosis Revenue in 2021
    3.5 Stem Cell Therapy for Multiple Sclerosis Key Players Head office and Area Served
    3.6 Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service
    3.7 Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy for Multiple Sclerosis Breakdown Data by Type
    4.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Type (2017-2022)
    4.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Type (2023-2028)
5 Stem Cell Therapy for Multiple Sclerosis Breakdown Data by Application
    5.1 Global Stem Cell Therapy for Multiple Sclerosis Historic Market Size by Application (2017-2022)
    5.2 Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Stem Cell Therapy for Multiple Sclerosis Market Size (2017-2028)
    6.2 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022)
    6.3 North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Stem Cell Therapy for Multiple Sclerosis Market Size (2017-2028)
    7.2 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022)
    7.3 Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size (2017-2028)
    8.2 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022)
    8.3 Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size (2017-2028)
    9.2 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022)
    9.3 Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size (2017-2028)
    10.2 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022)
    10.3 Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 American CryoStem
        11.1.1 American CryoStem Company Detail
        11.1.2 American CryoStem Business Overview
        11.1.3 American CryoStem Stem Cell Therapy for Multiple Sclerosis Introduction
        11.1.4 American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)
        11.1.5 American CryoStem Recent Development
    11.2 Athersys
        11.2.1 Athersys Company Detail
        11.2.2 Athersys Business Overview
        11.2.3 Athersys Stem Cell Therapy for Multiple Sclerosis Introduction
        11.2.4 Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)
        11.2.5 Athersys Recent Development
    11.3 Celgene Cellular Therapeutics
        11.3.1 Celgene Cellular Therapeutics Company Detail
        11.3.2 Celgene Cellular Therapeutics Business Overview
        11.3.3 Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Introduction
        11.3.4 Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)
        11.3.5 Celgene Cellular Therapeutics Recent Development
    11.4 Cell Cure Neurosciences
        11.4.1 Cell Cure Neurosciences Company Detail
        11.4.2 Cell Cure Neurosciences Business Overview
        11.4.3 Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Introduction
        11.4.4 Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)
        11.4.5 Cell Cure Neurosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Intravenous
    Table 3. Key Players of Intracerebroventricular
    Table 4. Global Stem Cell Therapy for Multiple Sclerosis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2017-2022)
    Table 8. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2023-2028)
    Table 10. Stem Cell Therapy for Multiple Sclerosis Market Trends
    Table 11. Stem Cell Therapy for Multiple Sclerosis Market Drivers
    Table 12. Stem Cell Therapy for Multiple Sclerosis Market Challenges
    Table 13. Stem Cell Therapy for Multiple Sclerosis Market Restraints
    Table 14. Global Stem Cell Therapy for Multiple Sclerosis Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players (2017-2022)
    Table 16. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2021)
    Table 17. Ranking of Global Top Stem Cell Therapy for Multiple Sclerosis Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Stem Cell Therapy for Multiple Sclerosis Product Solution and Service
    Table 21. Date of Enter into Stem Cell Therapy for Multiple Sclerosis Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2017-2022)
    Table 25. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Type (2023-2028)
    Table 27. Global Stem Cell Therapy for Multiple Sclerosis Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Application (2017-2022)
    Table 29. Global Stem Cell Therapy for Multiple Sclerosis Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Stem Cell Therapy for Multiple Sclerosis Revenue Market Share by Application (2023-2028)
    Table 31. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size by Country (2023-2028) & (US$ Million)
    Table 41. American CryoStem Company Detail
    Table 42. American CryoStem Business Overview
    Table 43. American CryoStem Stem Cell Therapy for Multiple Sclerosis Product
    Table 44. American CryoStem Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022) & (US$ Million)
    Table 45. American CryoStem Recent Development
    Table 46. Athersys Company Detail
    Table 47. Athersys Business Overview
    Table 48. Athersys Stem Cell Therapy for Multiple Sclerosis Product
    Table 49. Athersys Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022) & (US$ Million)
    Table 50. Athersys Recent Development
    Table 51. Celgene Cellular Therapeutics Company Detail
    Table 52. Celgene Cellular Therapeutics Business Overview
    Table 53. Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Product
    Table 54. Celgene Cellular Therapeutics Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022) & (US$ Million)
    Table 55. Celgene Cellular Therapeutics Recent Development
    Table 56. Cell Cure Neurosciences Company Detail
    Table 57. Cell Cure Neurosciences Business Overview
    Table 58. Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Product
    Table 59. Cell Cure Neurosciences Revenue in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022) & (US$ Million)
    Table 60. Cell Cure Neurosciences Recent Development
    Table 61. Research Programs/Design for This Report
    Table 62. Key Data Information from Secondary Sources
    Table 63. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Type: 2021 VS 2028
    Figure 2. Intravenous Features
    Figure 3. Intracerebroventricular Features
    Figure 4. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Application in 2021 & 2028
    Figure 5. Relapsing-Remitting Multiple Sclerosis (RRMS) Case Studies
    Figure 6. Primary Progressive Multiple Sclerosis (PPMS) Case Studies
    Figure 7. Secondary Progressive Multiple Sclerosis (SPMS) Case Studies
    Figure 8. Progressive Relapsing Multiple Sclerosis (PRMS) Case Studies
    Figure 9. Stem Cell Therapy for Multiple Sclerosis Report Years Considered
    Figure 10. Global Stem Cell Therapy for Multiple Sclerosis Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Stem Cell Therapy for Multiple Sclerosis Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Region: 2021 VS 2028
    Figure 13. Global Stem Cell Therapy for Multiple Sclerosis Market Share by Players in 2021
    Figure 14. Global Top Stem Cell Therapy for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Multiple Sclerosis as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Multiple Sclerosis Revenue in 2021
    Figure 16. North America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2017-2028)
    Figure 18. United States Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2017-2028)
    Figure 22. Germany Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Stem Cell Therapy for Multiple Sclerosis Market Share by Region (2017-2028)
    Figure 30. China Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2017-2028)
    Figure 38. Mexico Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Stem Cell Therapy for Multiple Sclerosis Market Share by Country (2017-2028)
    Figure 42. Turkey Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Stem Cell Therapy for Multiple Sclerosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. American CryoStem Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)
    Figure 45. Athersys Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)
    Figure 46. Celgene Cellular Therapeutics Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)
    Figure 47. Cell Cure Neurosciences Revenue Growth Rate in Stem Cell Therapy for Multiple Sclerosis Business (2017-2022)
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
American CryoStem
Athersys
Celgene Cellular Therapeutics
Cell Cure Neurosciences
Frequently Asked Questions
Stem Cell Therapy for Multiple Sclerosis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Stem Cell Therapy for Multiple Sclerosis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Stem Cell Therapy for Multiple Sclerosis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Sterility Testing

Sterility Testing market is segmented by players, region (country), by Type and by Application. P ... Read More

Stethoscopes

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Stick Packaging

Stick Packaging market is segmented by players, region (country), by Type and by Application. Pla ... Read More